| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A DNA vaccine against GII.4 human norovirus VP1 induces blocking antibody production and T cell responses
|
Kim, Na-Eun
|
|
|
42 |
6 |
p. 1392-1400
|
artikel
|
| 2 |
Antibodies against SARS-CoV-2 non-structural protein 3 cross-react with human muscle cells and neuroglial cells
|
Yang, Xin-Yue
|
|
|
42 |
6 |
p. 1259-1267
|
artikel
|
| 3 |
A review of potential use cases for measles-rubella, measles-mumps-rubella, and typhoid-conjugate vaccines presented on microarray patches
|
Soble, Adam
|
|
|
42 |
6 |
p. 1230-1246
|
artikel
|
| 4 |
Association between regular physical activity and pneumonia-related hospitalization according to pneumococcal vaccination status: The VENUS study
|
Murata, Fumiko
|
|
|
42 |
6 |
p. 1268-1274
|
artikel
|
| 5 |
Costs of human papillomavirus vaccine delivery in low- and middle-income countries: A systematic review
|
Slavkovsky, Rose
|
|
|
42 |
6 |
p. 1200-1210
|
artikel
|
| 6 |
Development of a live-attenuated chimeric vaccine against the emerging Usutu virus
|
Wang, Zheng-Jian
|
|
|
42 |
6 |
p. 1363-1371
|
artikel
|
| 7 |
Editorial Board
|
|
|
|
42 |
6 |
p. ii
|
artikel
|
| 8 |
Effectiveness of 13-valent pneumococcal conjugate vaccine against vaccine-serotype community acquired pneumococcal diseases among children in China: A test-negative case-control study
|
Xiaofei, LIU
|
|
|
42 |
6 |
p. 1275-1282
|
artikel
|
| 9 |
Efficacy of novel staphylococcal surface associated protein vaccines against Staphylococcus aureus and non-aureus staphylococcal mastitis in dairy cows
|
Vidlund, Jessica
|
|
|
42 |
6 |
p. 1247-1258
|
artikel
|
| 10 |
Immunogenicity of an adenovirus-vectored bivalent vaccine against wild type SARS-CoV-2 and Omicron variants in a murine model
|
Ji, Yuanyuan
|
|
|
42 |
6 |
p. 1292-1299
|
artikel
|
| 11 |
Infection-mediated immune response in SARS-CoV-2 breakthrough infection and implications for next-generation COVID-19 vaccine development
|
Miyamoto, Sho
|
|
|
42 |
6 |
p. 1401-1406
|
artikel
|
| 12 |
Live attenuated smallpox vaccine candidate (KVAC103) efficiently induces protective immune responses in mice
|
Hwang, Yun-Ho
|
|
|
42 |
6 |
p. 1283-1291
|
artikel
|
| 13 |
Modelling the health and economic impacts ofM72/AS01E vaccination and BCG-revaccination: Estimates for South Africa
|
Sumner, Tom
|
|
|
42 |
6 |
p. 1311-1318
|
artikel
|
| 14 |
Obstetric and neonatal outcomes in South Africa
|
Cutland, Clare L.
|
|
|
42 |
6 |
p. 1352-1362
|
artikel
|
| 15 |
One-year follow-up of the immunogenicity and safety of a primary series of the NVX-CoV2373 (TAK-019) vaccine in healthy Japanese adults: Final report of a phase I/II randomized controlled trial
|
Kuriyama, Kenji
|
|
|
42 |
6 |
p. 1319-1325
|
artikel
|
| 16 |
Prokaryote-derived phosphorylated Tau epitope vaccine is immunogenic and non-T-cell activated in the mice model
|
Chen, Mo
|
|
|
42 |
6 |
p. 1211-1219
|
artikel
|
| 17 |
Protective effect against toxoplasmosis in BALB/C mice vaccinated with recombinant Toxoplasma gondii CDPK3, GRA35, and ROP46 protein cocktail vaccine
|
Li, Dan
|
|
|
42 |
6 |
p. 1342-1351
|
artikel
|
| 18 |
Public opinion on global COVID-19 vaccine procurement and distribution policies: A nationally representative survey in Aotearoa New Zealand 2022
|
Kolandai, Komathi
|
|
|
42 |
6 |
p. 1372-1382
|
artikel
|
| 19 |
Safety of a second homologous Ad26.COV2.S vaccine among healthcare workers in the phase 3b implementation Sisonke study in South Africa
|
Takalani, Azwidihwi
|
|
|
42 |
6 |
p. 1195-1199
|
artikel
|
| 20 |
Safety of incidental exposure to the novel oral poliovirus vaccine type 2 in pregnancy: A longitudinal observational study in Mozambique, 2022–2023
|
de Deus, Nilsa
|
|
|
42 |
6 |
p. 1326-1331
|
artikel
|
| 21 |
Strong immunogenicity & protection in mice with PlaCCine: A COVID-19 DNA vaccine formulated with a functional polymer
|
Sood, Subeena
|
|
|
42 |
6 |
p. 1300-1310
|
artikel
|
| 22 |
The impact of Covid-19 vaccination in Aotearoa New Zealand: A modelling study
|
Datta, Samik
|
|
|
42 |
6 |
p. 1383-1391
|
artikel
|
| 23 |
The mental health symptoms of individuals with sensory disabilities and the reasons that lead to COVID-19 vaccine refusal and hesitancy
|
Hinson-Enslin, Amanda M.
|
|
|
42 |
6 |
p. 1220-1229
|
artikel
|
| 24 |
Utilizing a university testing program to estimate relative effectiveness of monovalent COVID-19 mRNA booster vaccine versus two-dose primary series against symptomatic SARS-CoV-2 infection
|
Bennett, Julia C.
|
|
|
42 |
6 |
p. 1332-1341
|
artikel
|
Tijdschrift beschrijving